ADTRAN Holdings, Inc.

Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: ADTRAN Holdings, Inc. |
Ticker: | Ticker: ADTN |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ:ADTN). The investigation concerns whether ADTRAN and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On May 13, 2025, ADTRAN disclosed in a filing with the U.S. Securities and Exchange Commission that “the Company’s (i) audited consolidated financial statements as of and for the years ended December 31, 2024 (‘Fiscal 2024’) and December 31, 2023 (‘Fiscal 2023’) included in the Company’s Annual Report on Form 10-K filed with the SEC on March 3, 2025 (the ‘2024 Form 10-K’), and (ii) unaudited condensed financial statements as of and for the interim periods ended March 31, 2024, June 30, 2024 and September 30, 2024 (the ‘2024 Interim Periods’) included in the Company’s Quarterly Reports filed with the SEC on May 10, 2024, August 9, 2024, and November 12, 2024, respectively (such 2024 Interim Periods, collectively with Fiscal 2024 and Fiscal 2023, the ‘Non-Reliance Periods’), as well as the relevant portions of any communication which describe or are based on such financial statements, should no longer be relied upon” and would be restated. ADTRAN stated that “management is evaluating the impact of this matter on its internal control over financial reporting as of December 31, 2024, and has identified at least one additional material weakness.” On this news, the price of ADTRAN shares declined by $0.41 per share, from $8.56 per share on May 13, 2025, to close at $8.15 on May 14, 2025.
On May 13, 2025, ADTRAN disclosed in a filing with the U.S. Securities and Exchange Commission that “the Company’s (i) audited consolidated financial statements as of and for the years ended December 31, 2024 (‘Fiscal 2024’) and December 31, 2023 (‘Fiscal 2023’) included in the Company’s Annual Report on Form 10-K filed with the SEC on March 3, 2025 (the ‘2024 Form 10-K’), and (ii) unaudited condensed financial statements as of and for the interim periods ended March 31, 2024, June 30, 2024 and September 30, 2024 (the ‘2024 Interim Periods’) included in the Company’s Quarterly Reports filed with the SEC on May 10, 2024, August 9, 2024, and November 12, 2024, respectively (such 2024 Interim Periods, collectively with Fiscal 2024 and Fiscal 2023, the ‘Non-Reliance Periods’), as well as the relevant portions of any communication which describe or are based on such financial statements, should no longer be relied upon” and would be restated. ADTRAN stated that “management is evaluating the impact of this matter on its internal control over financial reporting as of December 31, 2024, and has identified at least one additional material weakness.” On this news, the price of ADTRAN shares declined by $0.41 per share, from $8.56 per share on May 13, 2025, to close at $8.15 on May 14, 2025.